Targeted therapy with Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of solid tumours
<p align="justify">Introduction: According to the National Cancer Register in Poland, the number of cancers including breast cancers has more than doubled in the past three decades. Poly(ADP-ribose) polymerase (PARP) inhibitors lead to the death of cells with a <em>BRCA1/2 <...
Saved in:
Main Authors: | Faustyna Piędel (Author), Agata Agnieszka Rocka (Author), Klaudia Daria Szumna (Author), Dominika Katarzyna Madras (Author), Patryk Piotr Jasielski (Author) |
---|---|
Format: | Book |
Published: |
Kazimierz Wielki University,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Poly(ADP-ribose) polymerase (PARP) inhibitors and ovarian cancer
by: Chia-Hao Liu, et al.
Published: (2017) -
Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy
by: Stephen A. Jannetti, et al.
Published: (2020) -
Does SSRI have a neuroprotective effect in patent after ischemic stroke?
by: Agata Rocka, et al.
Published: (2020) -
Deep brain stimulation in Parkinson's disease - the review
by: Patryk Piotr Jasielski, et al.
Published: (2020) -
Potential biological role of poly (ADP-ribose) polymerase (PARP) in male gametes
by: Sarkar Oli, et al.
Published: (2009)